Granite Bay Wealth Management, LLC Eli Lilly & CO Transaction History

Granite Bay Wealth Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 21, 2024	BUY	$724.87 - $909.04 $258,053 - $323,618	356 New	356 $323,000
Q4 2023 Jan 29, 2024	BUY	$525.19 - $619.13 $19,957 - $23,526	38 Added 0.47%	8,057 $4.7 Million
Q3 2023 Oct 12, 2023	BUY	$434.7 - $599.3 $3.49 Million - $4.81 Million	8,019 New	8,019 $4.21 Million

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Granite Bay Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Granite Bay Wealth Management, LLC with notifications on news.